Company intelligence / Profile preview

LabPLUS

Ownership: Private
Development stage: Commercial

Overview

The main “Labplus” offers a clinically validated software platform that enables patients/doctors to interpret laboratory test results quickly and accurately online or via app interface. It aims to reduce delays in care by making actionable insights from bloodwork accessible without waiting for doctor appointments. The Korean “Young In Labplus” supplies advanced research antibodies, high-purity water systems (“AQUAPURI”), diagnostic kits, and consulting/design services for laboratories worldwide with over four decades of experience in science R&D infrastructure support. No clinical trial pipeline exists since these are service/product companies rather than drug developers.

Modalities: AntibodyDiagnostic kit
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on LabPLUS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LabPLUS.

Explore the full profile